1. Microvessel density and angiogenesis in primary hepatic malignancies: Differential expression of CD31 and VEGFR-2 in hepatocellular carcinoma and intrahepatic cholangiocarcinoma
   Hans Bösmüller et al, 2018, Pathology - Research and Practice CrossRef
2. Anticancer Effects of Gleditsia sinensis Extract in Rats Transplanted With Hepatocellular Carcinoma Cells
   Yue Cai et al, 2019, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
3. Yes-associated protein: A novel molecular target for the diagnosis, treatment and prognosis of hepatocellular carcinoma
   Liang Shan et al, 2017, Oncology Letters CrossRef
4. GTSF1 gene may serve as a novel potential diagnostic biomarker for liver cancer
   De‑Yong Gao et al, 2017, Oncology Letters CrossRef
5. Identification of novel lactate metabolism signatures and molecular subtypes for prognosis in hepatocellular carcinoma
   Qiutong Guan et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
6. Knockdown of RRS1 by lentiviral-mediated RNAi promotes apoptosis and suppresses proliferation of human hepatocellular carcinoma cells
   Jitao Wang et al, 2017, Oncology Reports CrossRef
7. Immunological inflammatory biomarkers as prognostic predictors for advanced hepatocellular carcinoma
   M. Nakano et al, 2021, ESMO Open CrossRef
8. Unleashing the potential of gene signatures as prognostic and predictive tools: A step closer to personalized medicine in hepatocellular carcinoma (HCC)
   Atieh Pourbagheri‐Sigaroodi et al, 2024, Cell Biochemistry and Function CrossRef